PULMONARY EMBOLISM ACUTE MASSIVE
Clinical trials for PULMONARY EMBOLISM ACUTE MASSIVE explained in plain language.
Never miss a new study
Get alerted when new PULMONARY EMBOLISM ACUTE MASSIVE trials appear
Sign up with your email to follow new studies for PULMONARY EMBOLISM ACUTE MASSIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Clot-Busting catheter approach could save lives in severe lung clot emergencies
Disease control Recruiting nowThis study tests whether using a catheter early to break up blood clots in the lungs, along with standard care, can reduce death and prevent the heart from failing again. About 210 people with severe, life-threatening pulmonary embolism will be randomly assigned to get either the…
Matched conditions: PULMONARY EMBOLISM ACUTE MASSIVE
Phase: NA • Sponsor: Leipzig Heart Science gGmbH • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Massive PE study tests new clot-buster on 20,000 patients
Disease control Recruiting nowThis study is tracking how safe and effective a drug called non-immunogenic staphylokinase is for people with a massive blood clot in the lungs (pulmonary embolism). Researchers will follow 20,000 adults who receive this clot-busting medicine in regular hospital care. The main go…
Matched conditions: PULMONARY EMBOLISM ACUTE MASSIVE
Sponsor: Supergene, LLC • Aim: Disease control
Last updated May 13, 2026 16:03 UTC